Dinoy, Elpidio A.
HRN: 23-94-41 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2023
CEFTRIAXONE 1G (VIAL)
10/20/2023
10/26/2023
IVTT
2 Grams
Q24h
CAP-MR, R/O PTB, CAD, HASCVD, Arrhythmia, CHF STAGE C, FC IV
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaCardiovascular Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes